These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23692573)

  • 41. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
    Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
    JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early experience with community implementation of thrombolysis three to 4.5 hours after acute ischemic stroke.
    Alias M; Staff I; McCullough LD
    Conn Med; 2011 Oct; 75(9):531-6. PubMed ID: 22308640
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features.
    Guillan M; Alonso-Canovas A; Gonzalez-Valcarcel J; Garcia Barragan N; Garcia Caldentey J; Hernandez-Medrano I; Defelipe-Mimbrera A; Sanchez-Gonzalez V; Terecoasa E; Alonso de Leciñana M; Masjuan J
    Cerebrovasc Dis; 2012; 34(2):115-20. PubMed ID: 22854315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study.
    Amlie-Lefond C; deVeber G; Chan AK; Benedict S; Bernard T; Carpenter J; Dowling MM; Fullerton H; Hovinga C; Kirton A; Lo W; Zamel K; Ichord R;
    Lancet Neurol; 2009 Jun; 8(6):530-6. PubMed ID: 19423401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic resonance imaging-based versus computed tomography-based thrombolysis in acute ischemic stroke: comparison of safety and efficacy within a cohort study.
    Gerischer LM; Fiebach JB; Scheitz JF; Audebert HJ; Endres M; Nolte CH
    Cerebrovasc Dis; 2013; 35(3):250-6. PubMed ID: 23548768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of cerebral thrombolysis in an extended 'time window'.
    Sobolewski P; Kozera G; Kaźmierski R; Michalak S; Szczuchniak W; Nyka W
    J Clin Pharm Ther; 2015 Aug; 40(4):472-6. PubMed ID: 26059848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and feasibility of a lower dose intravenous TPA therapy for ischemic stroke beyond the first three hours.
    Uchino K; Alexandrov AV; Garami Z; El-Mitwalli A; Morgenstern LB; Grotta JC
    Cerebrovasc Dis; 2005; 19(4):260-6. PubMed ID: 15731557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Challenges of Thrombolysis in a Developing Country: Characteristics and Outcomes in Peru.
    Abanto C; Valencia A; Calle P; Barrientos D; Flores N; Novoa M; Ecos RL; Ramirez JA; Ulrich AK; Zunt JR; Tirschwell DL; Wahlster S
    J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104819. PubMed ID: 32307317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of off-label stroke treatment with tissue plasminogen activator.
    Kvistad CE; Logallo N; Thomassen L; Waje-Andreassen U; Brøgger J; Naess H
    Acta Neurol Scand; 2013 Jul; 128(1):48-53. PubMed ID: 23311439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit.
    Yoneda Y; Yamamoto S; Hara Y; Ohta K; Matsushita M; Yamamoto D; Yamashita H; Hosoda K
    Clin Neurol Neurosurg; 2007 Sep; 109(7):567-70. PubMed ID: 17573188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Benefits of intravenous thrombolysis in acute ischemic stroke related to extra cranial internal carotid dissection. Dream or reality?
    Fuentes B; Masjuan J; Alonso de Leciñana M; Simal P; Egido J; Díaz-Otero F; Gil-Nuñez A; Martínez-Sánchez P; Díez-Tejedor E;
    Int J Stroke; 2012 Jan; 7(1):7-13. PubMed ID: 22017881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Stroke Outcomes of Hub and Spoke Hospital Treated Patients in Mayo Clinic Telestroke Program.
    Demaerschalk BM; Boyd EL; Barrett KM; Gamble DM; Sonchik S; Comer MM; Wieser J; Hentz JG; Fitz-Patrick D; Chang YH
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2940-2942. PubMed ID: 30146388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
    Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
    J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Teoh HL; Chan BP
    Expert Rev Neurother; 2012 Feb; 12(2):209-17. PubMed ID: 22288676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.
    Dong Y; Han Y; Shen H; Wang Y; Ma F; Li H; Wang Y; Dong Q
    Stroke Vasc Neurol; 2020 Dec; 5(4):348-352. PubMed ID: 32611728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of the Drip-and-Ship Paradigm for Patients with Acute Ischemic Stroke in South Korea.
    Park MS; Lee JS; Park TH; Cho YJ; Hong KS; Park JM; Kang K; Lee KB; Kim JG; Lee SJ; Lee J; Choi KH; Kim JT; Cho KH; Oh MS; Yu KH; Lee BC; Cha JK; Kim DH; Nah HW; Lee J; Kim DE; Ryu WS; Kim BJ; Han MK; Bae HJ; Song SK; Choi JC
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2678-2687. PubMed ID: 27480820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Four-Year Experience of Symptomatic Intracranial Hemorrhage Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center.
    Orlando A; Wagner JC; Fanale CV; Whaley M; McCarthy KL; Bar-Or D
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):969-76. PubMed ID: 26856464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thrombolysis with alteplase 3-4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China.
    Zheng H; Yang Y; Chen H; Li C; Chen Y; Shi FD; Yang L; Cui X; Lu Z; Liang Y; Cui S; Xu A; Wu Y; Sun Y; Wang Y
    Stroke Vasc Neurol; 2020 Sep; 5(3):285-290. PubMed ID: 32467323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.